Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-29

Clinical Trial Update: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome [NA]

View source ↗

Summary

A Stanford University trial is currently recruiting to evaluate the use of low-dose naltrexone for complex regional pain syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: Stanford University | Conditions: Complex Regional Pain Syndrome | NA | Status: RECRUITING